A new study published last week by The Lancet Oncology(link is external) is the first of its kind to examine the economic burden of cancer in Syrian refugee populations. It estimates that 3,000-7,000 euros per cancer case would be sufficient to provide good quality care. This amounts to 11% of the current annual budget of US$ 345 million for Syrian refugees in Jordan, Lebanon and Turkey (2017 figures).
The Union for International Cancer Control (UICC) spoke with two of the study’s authors, Dr Deborah Mukherji and Dr Omar Shamieh. Read the Q&A here.
